UM Shore Regional Health has entered into a new partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology team to provide professional and management services at the Requard Radiation Oncology Center in the Cancer Center at UM Shore Regional Health. This integration will provide increased access to state-of-the-art technologies and innovative clinical trials, in addition to the full spectrum radiation therapies and precise treatments the Cancer Center offers to patients on the Eastern Shore.
During the past 35 years, John Mastandrea, MD, chief, Radiation Oncology at UM SRH, has successfully built an outstanding team and patient care program at Requard Radiation Oncology Center, which offers state-of-the-art technology including stereotactic radiation and brachytherapy, a form of radiotherapy through which a sealed radiation source is placed inside or next to the area requiring treatment. Dr. Mastandrea’s continued commitment to providing the highest quality cancer care to patients throughout the Eastern Shore has been a catalyst for this new partnership.
Continuing as chief, Radiation Oncology at the Cancer Center at UM SRH and as a provider with University of Maryland Shore Medical Group, Dr. Mastandrea will work closely with Emily Kowalski, MD, newly-appointed medical director, Requard Radiation Oncology Center, to further develop the robust clinical program at the radiation therapy center.
A radiation oncologist with extensive additional experience as a certified public accountant, Dr. Kowalski graduated from the UM School of Medicine and completed her residency at the UM Department of Radiation Oncology, where she served as chief resident. Her areas of practice and research interests include innovative approaches to breast cancer treatment and various aspects of brain radiation. Dr. Kowalski also earned her undergraduate degree from the Tulane University Freeman School of Business after which she worked for a top-tier New York financial firm. Her decision to pursue radiation oncology was made while caring for a close family member with cancer.
The team will work closely with Mary Deshields, MD, medical director, UM SMG – Oncology and Clinical Trials at UM SRH, and with the UM Department of Radiation Oncology’s MS clinical trial research leadership to promote and grow the existing radiation oncology-based clinical trials and research protocols.
Information about cancer care provided by University of Maryland Shore Regional Health may be obtained by calling 410-820-6800, or visiting https://www.umms.org/shore/health-services/cancer